These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6231385)

  • 1. Morbilliform skin eruption owing to diethylstilbestrol.
    Lee M; Sharifi R
    J Urol; 1984 Apr; 131(4):767-8. PubMed ID: 6231385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilantin hypersensitivity reaction.
    Conger LA; Grabski WJ
    Cutis; 1996 Apr; 57(4):223-6. PubMed ID: 8727770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancytopenia, rash and fever caused by diethylstilbestrol used for prostate cancer.
    Collins D
    J Rheumatol; 1989 Mar; 16(3):408-9. PubMed ID: 2724259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug hypersensitivity reactions presenting as a morbilliform eruption with islands of sparing.
    Colaco SM; Bakr FS; Silvers DN; Grossman ME
    Cutis; 2012 Apr; 89(4):173-4. PubMed ID: 22611744
    [No Abstract]   [Full Text] [Related]  

  • 6. Maculopapular skin eruptions associated with Covid-19: A systematic review.
    Shams S; Rathore SS; Anvekar P; Sondhi M; Kancherla N; Tousif S; Rojas GA; Ahmed NK; Munawwar M; Noman M
    Dermatol Ther; 2021 Mar; 34(2):e14788. PubMed ID: 33481314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maculopapular type drug eruption caused by pregabalin: A case and literature review.
    Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
    Allergol Int; 2016 Jul; 65(3):351-2. PubMed ID: 26976337
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed hypersensitivity reaction resulting in maculopapular-type eruption due to entecavir in the treatment of chronic hepatitis B.
    Kim JT; Jeong HW; Choi KH; Yoon TY; Sung N; Choi YK; Kim EH; Chae HB
    World J Gastroenterol; 2014 Nov; 20(42):15931-6. PubMed ID: 25400481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maculopapular type drug eruption caused by silodosin.
    Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nisio D; Nakamura M
    Allergol Int; 2016 Apr; 65(2):219-220. PubMed ID: 26806055
    [No Abstract]   [Full Text] [Related]  

  • 10. Widespread morbilliform eruption associated with telaprevir: use of dermatologic consultation to increase tolerability.
    Strazzula L; Pratt DS; Zardas J; Chung RT; Thiim M; Kroshinsky D
    JAMA Dermatol; 2014 Jul; 150(7):756-9. PubMed ID: 24718650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse morbilliform eruption after consumption of ginkgo biloba supplement.
    Chiu AE; Lane AT; Kimball AB
    J Am Acad Dermatol; 2002 Jan; 46(1):145-6. PubMed ID: 11756966
    [No Abstract]   [Full Text] [Related]  

  • 12. Morbilliform drug eruption due to pegylated α-interferon can show complete regression after switching to non-pegylated interferon.
    Barut S; Yuksek J; Sezer E; Gunal O; Koseoglu D
    J Dermatol; 2011 May; 38(5):479-81. PubMed ID: 21352322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of delayed cellular hypersensitivity and adhesion molecules in amoxicillin-induced morbilliform rashes.
    Barbaud AM; Béné MC; Schmutz JL; Ehlinger A; Weber M; Faure GC
    Arch Dermatol; 1997 Apr; 133(4):481-6. PubMed ID: 9126012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug eruptions in children with ENT infections.
    Rallis E; Balatsouras DG; Kouskoukis C; Verros C; Homsioglou E
    Int J Pediatr Otorhinolaryngol; 2006 Jan; 70(1):53-7. PubMed ID: 15978677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ampicillin rash as a diagnostic and management problem: case reports and literature review.
    Geyman JP; Erickson S
    J Fam Pract; 1978 Sep; 7(3):493-6. PubMed ID: 151125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dermatitis medicamentosa].
    Veltman G
    Med Welt; 1967 Dec; 48():2894-903. PubMed ID: 4237804
    [No Abstract]   [Full Text] [Related]  

  • 17. Two contrasting post-zoster dermatomal phenomena.
    Sultan SJ; Sameem F
    Skinmed; 2012; 10(5):312-4. PubMed ID: 23163077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symptomatology and markers of the severity of erythematous drug eruptions].
    Djien V; Bocquet H; Dupuy A; Revuz J; Roujeau JC
    Ann Dermatol Venereol; 1999 Mar; 126(3):247-50. PubMed ID: 10394438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxiderma induced by fosfestrol (ST52)].
    Fradet G; Deniaud C; Le Nechet A; Charlois T
    Ann Med Interne (Paris); 1997; 148(3):290-2. PubMed ID: 9255344
    [No Abstract]   [Full Text] [Related]  

  • 20. A fixed drug eruption due to paracetamol.
    Wilson HT
    Br J Dermatol; 1975 Feb; 92(2):213-4. PubMed ID: 125095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.